John Inge Johnsen

8.3k total citations
111 papers, 4.1k citations indexed

About

John Inge Johnsen is a scholar working on Molecular Biology, Neurology and Cancer Research. According to data from OpenAlex, John Inge Johnsen has authored 111 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 58 papers in Neurology and 29 papers in Cancer Research. Recurrent topics in John Inge Johnsen's work include Neuroblastoma Research and Treatments (58 papers), Cancer, Hypoxia, and Metabolism (23 papers) and Cancer therapeutics and mechanisms (10 papers). John Inge Johnsen is often cited by papers focused on Neuroblastoma Research and Treatments (58 papers), Cancer, Hypoxia, and Metabolism (23 papers) and Cancer therapeutics and mechanisms (10 papers). John Inge Johnsen collaborates with scholars based in Sweden, Norway and United States. John Inge Johnsen's co-authors include Per Kogner, Baldur Sveinbjørnsson, Malin Wickström, Cecilia Dyberg, Ninib Baryawno, Marie Arsenian‐Henriksson, Ami Albihn, Frida Ponthan, Helena Gleissman and Lova Segerström and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

John Inge Johnsen

110 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Inge Johnsen Sweden 41 2.2k 1.2k 1.1k 1.0k 577 111 4.1k
Gregory Hollis United States 36 2.7k 1.2× 1.0k 0.9× 328 0.3× 369 0.4× 996 1.7× 101 5.1k
Grazia Ambrosini United States 27 4.8k 2.2× 2.2k 1.9× 223 0.2× 743 0.7× 1.2k 2.1× 48 6.8k
Jonas A. Nilsson Sweden 38 5.5k 2.5× 2.0k 1.7× 191 0.2× 2.1k 2.0× 1.5k 2.5× 110 7.8k
Simon N. Willis Australia 24 4.9k 2.3× 1.7k 1.5× 248 0.2× 626 0.6× 2.0k 3.5× 36 7.2k
Bharat Joshi United States 42 2.8k 1.3× 1.1k 0.9× 249 0.2× 488 0.5× 1.6k 2.9× 109 5.5k
Natalie Roy Canada 10 3.8k 1.7× 1.1k 0.9× 121 0.1× 706 0.7× 924 1.6× 13 5.0k
Shigeru Sakiyama Japan 34 2.4k 1.1× 935 0.8× 191 0.2× 709 0.7× 634 1.1× 124 3.8k
B. Nelson Chau United States 24 3.1k 1.4× 541 0.5× 172 0.2× 1.4k 1.3× 310 0.5× 33 4.1k
Konstantin Shilo United States 32 1.4k 0.6× 957 0.8× 172 0.2× 637 0.6× 499 0.9× 101 3.3k
Allen Oliff United States 43 4.1k 1.9× 2.6k 2.2× 157 0.1× 562 0.6× 883 1.5× 107 6.7k

Countries citing papers authored by John Inge Johnsen

Since Specialization
Citations

This map shows the geographic impact of John Inge Johnsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Inge Johnsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Inge Johnsen more than expected).

Fields of papers citing papers by John Inge Johnsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Inge Johnsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Inge Johnsen. The network helps show where John Inge Johnsen may publish in the future.

Co-authorship network of co-authors of John Inge Johnsen

This figure shows the co-authorship network connecting the top 25 collaborators of John Inge Johnsen. A scholar is included among the top collaborators of John Inge Johnsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Inge Johnsen. John Inge Johnsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sarkar, Hirak, Jörg Otte, Thale Kristin Olsen, et al.. (2025). Comparative Single-Cell Transcriptomics of Human Neuroblastoma and Preclinical Models Reveals Conservation of an Adrenergic Cell State. Cancer Research. 85(6). 1015–1034. 2 indexed citations
2.
Treis, Diana, Kristina Lundberg, Emma Åkerlund, et al.. (2025). Targeted inhibition of WIP1 and histone H3K27 demethylase activity synergistically suppresses neuroblastoma growth. Cell Death and Disease. 16(1). 318–318. 1 indexed citations
3.
Treis, Diana, Emma Åkerlund, Brinton Seashore‐Ludlow, et al.. (2024). The ROCK-1/2 inhibitor RKI-1447 blocks N-MYC, promotes cell death, and emerges as a synergistic partner for BET inhibitors in neuroblastoma. Cancer Letters. 605. 217261–217261. 2 indexed citations
4.
Mei, Shenglin, Bronte Manouk Verhoeven, Ting Zhao, et al.. (2024). Single-cell analyses of metastatic bone marrow in human neuroblastoma reveals microenvironmental remodeling and metastatic signature. JCI Insight. 9(6). 8 indexed citations
5.
Vaid, Roshan, Rebeca Burgos‐Panadero, Anna Djos, et al.. (2023). METTL3 drives telomere targeting of TERRA lncRNA through m6A-dependent R-loop formation: a therapeutic target for ALT-positive neuroblastoma. Nucleic Acids Research. 52(5). 2648–2671. 27 indexed citations
6.
Yuan, Ye, Mohammad Alzrigat, Xueyao Wang, et al.. (2023). Target Genes of c-MYC and MYCN with Prognostic Power in Neuroblastoma Exhibit Different Expressions during Sympathoadrenal Development. Cancers. 15(18). 4599–4599. 4 indexed citations
7.
Olsen, Thale Kristin, Cecilia Dyberg, Jelena Milosevic, et al.. (2022). DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma. JCI Insight. 7(17). 21 indexed citations
8.
Zhang, Songbai, Ayako Miyakawa, Malin Wickström, et al.. (2022). GIT1 protects against breast cancer growth through negative regulation of Notch. Nature Communications. 13(1). 1537–1537. 11 indexed citations
9.
Zhou, Xiaolei, Yue Zhan, Mariana M.S. Oliveira, et al.. (2022). Mutant p53 gain of function mediates cancer immune escape that is counteracted by APR-246. British Journal of Cancer. 127(11). 2060–2071. 17 indexed citations
10.
Moens, Ugo, John Inge Johnsen, Virve Koljonen, et al.. (2022). The Merkel Cell Polyomavirus T-Antigens and IL-33/ST2-IL1RAcP Axis: Possible Role in Merkel Cell Carcinoma. International Journal of Molecular Sciences. 23(7). 3702–3702. 3 indexed citations
11.
Lundberg, Kristina, Diana Treis, & John Inge Johnsen. (2022). Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies. Current Oncology Reports. 24(8). 1053–1062. 45 indexed citations
12.
Milosevic, Jelena, Diana Treis, Susanne Fransson, et al.. (2021). PPM1D Is a Therapeutic Target in Childhood Neural Tumors. Cancers. 13(23). 6042–6042. 7 indexed citations
13.
Milosevic, Jelena, Susanne Fransson, Miklós Gulyás, et al.. (2021). High Expression of PPM1D Induces Tumors Phenotypically Similar to TP53 Loss-of-Function Mutations in Mice. Cancers. 13(21). 5493–5493. 8 indexed citations
14.
Mitra, Sanhita, Somsundar Veppil Muralidharan, Subazini Thankaswamy Kosalai, et al.. (2020). Subcellular Distribution of p53 by the p53-Responsive lncRNA NBAT1 Determines Chemotherapeutic Response in Neuroblastoma. Cancer Research. 81(6). 1457–1471. 25 indexed citations
15.
Dyberg, Cecilia, Thale Kristin Olsen, Bertha Brodin, et al.. (2019). Inhibition of Rho-Associated Kinase Suppresses Medulloblastoma Growth. Cancers. 12(1). 73–73. 10 indexed citations
16.
Wickström, Malin, Peter J. Coopman, Per Kogner, et al.. (2019). SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells In Vitro. Cancers. 11(2). 202–202. 7 indexed citations
17.
Gallo-Oller, Gabriel, Cecilie Løkke, Per Kogner, et al.. (2018). Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma. Oncogene. 38(15). 2800–2813. 44 indexed citations
18.
Mao, Yumeng, Nina Eißler, Katarina Le Blanc, et al.. (2016). Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma. Clinical Cancer Research. 22(15). 3849–3859. 107 indexed citations
19.
Chen, Zhi Xiong, Karin Wallis, Daniel Ramsköld, et al.. (2014). RNA Helicase A Is a Downstream Mediator of KIF1Bβ Tumor-Suppressor Function in Neuroblastoma. Cancer Discovery. 4(4). 434–451. 43 indexed citations
20.
Baryawno, Ninib, Baldur Sveinbjørnsson, Staffan Eksborg, et al.. (2009). Small-Molecule Inhibitors of Phosphatidylinositol 3-Kinase/Akt Signaling Inhibit Wnt/β-Catenin Pathway Cross-Talk and Suppress Medulloblastoma Growth. Cancer Research. 70(1). 266–276. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gregory Hollis Breakdown of academic impact, for papers by Grazia Ambrosini Breakdown of academic impact, for papers by Jonas A. Nilsson Breakdown of academic impact, for papers by Simon N. Willis Breakdown of academic impact, for papers by Bharat Joshi Breakdown of academic impact, for papers by Natalie Roy Breakdown of academic impact, for papers by Shigeru Sakiyama Breakdown of academic impact, for papers by B. Nelson Chau Breakdown of academic impact, for papers by Konstantin Shilo Breakdown of academic impact, for papers by Allen Oliff
Rankless by CCL
2026